Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ (HCP) Stock Forecast & Price Prediction | | |
$0.00
+0.00 (nan%)10 Quality Stocks Worth Considering Now
Researching HashiCorp (HCP) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on HCP and similar high-potential opportunities.
Comprehensive analyst forecasts are currently unavailable for HCP. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for HCP.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
The following stocks are similar to HashiCorp based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
has a market capitalization of $0 with a P/E ratio of 0.0x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of N/A and return on equity of N/A.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
The UK competition regulator will not conduct a Phase 2 investigation into IBM's $6.4 billion acquisition of HashiCorp.
The UK regulator's decision allows IBM to proceed with the acquisition, potentially boosting IBM's market position and growth prospects, which could positively impact its stock and investor confidence.
The U.K. antitrust authority has approved IBM's multibillion-dollar acquisition of infrastructure software company HashiCorp.
The approval signals reduced regulatory risk for IBM's acquisition, potentially enhancing its market position and growth prospects, which could positively influence investor sentiment and stock performance.
IBM has completed its acquisition of HashiCorp for several billion dollars, following approval from the U.K. antitrust regulator.
IBM's acquisition of HashiCorp enhances its cloud services portfolio, potentially driving growth and competitiveness, which could positively impact its stock performance and investor sentiment.
HashiCorp, Inc. (NASDAQ: HCP) will release its Q4 fiscal 2025 financial results on March 6, 2025, after U.S. market close.
HashiCorp's upcoming financial results are crucial for assessing its performance and growth potential, influencing investor sentiment and stock valuation.
MC, LFST, EAT, CYRX, and HCP were added to the Zacks Rank #1 (Strong Buy) List on January 29, 2024, indicating strong potential for investment.
The addition of MC, LFST, EAT, CYRX, and HCP to the Zacks Rank #1 (Strong Buy) List signals strong potential for price appreciation, attracting investor interest and possibly boosting stock performance.
Zacks Style Scores can help investors identify strong, market-beating stocks for their portfolios.
Zacks Style Scores can help identify high-potential stocks, guiding investors towards selections that may outperform the market, enhancing portfolio performance.
Analyst forecasts for (HCP) are not currently available. The stock is trading at $0.00.
Analyst ratings for HCP are not currently available. The stock is currently trading at $0.00. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for HCP are not currently available. The stock is trading at $0.00.
N/A
Price targets from Wall Street analysts for HCP are not currently available. The stock is trading at $0.00.
Price targets from Wall Street analysts for HCP are not currently available. The stock is trading at $0.00.
Analyst ratings for HCP are not currently available. The stock is trading at $0.00.
Stock price projections, including those for , are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.